$0.7740
-0.026-3.25%
Last update: Nov 12, 4:09 PM
InspireMD Inc
NSPRNASDAQ
InspireMD fell 56.8% from $1.79 to $0.77, behind the S&P 500's +11.2%. Its worst day was Nov 5 (−18.2%), and its low came Oct 20 at $0.44.
Nov 12, 2025 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
InspireMD shares rose 13.5%, while the S&P 500 rose 1.0%.
+13.5% · S&P 500 +1.0%
InspireMD closed at its highest level of the year, 20.1% above where the year started.
+1.4% · S&P 500 +0.5%
Story events cover the past 12 months · Times ET
EPS of $-0.14 beat the $-0.20 estimate on $3.1M revenue (est. $2.7M); FY revenue guidance of $13.0M–$15.0M against the $14.8M consensus.
+1.1% · S&P 500 −1.4%
EPS of $-0.16 beat the $-0.18 estimate on $3.4M revenue (est. $2.7M).
−6.0% · S&P 500 +0.8%
EPS of $-0.17 beat the $-0.20 estimate on $1.8M revenue (est. $1.4M).
−10.4% · S&P 500 −0.5%
InspireMD closed at its lowest level of the year, 75.5% below where the year started.
−1.4% · S&P 500 +0.3%
InspireMD shares rose 22.1%, while the S&P 500 rose 0.3%.
+22.1%, the year's best day · S&P 500 +0.3%
Where it ended: a close of $0.77 on Nov 12, 2026. Up next: Q3 2026 earnings on Nov 12, 2026 (EPS est. $-0.15, revenue est. $2.0M).
Nothing in the past 12 months.
All NSPR dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NSPR and SPY from Benzinga historical bars. Not investment advice.
